Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 22.86 | 14.84 |
| PEG Ratio (TTM) | -4.95 | -0.11 |
| P/S Ratio (TTM) | 1.91 | 2.61 |
| P/B Ratio (TTM) | 0.72 | 1.36 |
| P/FCF Ratio (TTM) | 17.10 | 5.85 |
| Price to 5YR AVG Earnings Ratio | N/A | 15.03 |
| Price to 5YR AVG FCF Ratio | N/A | 9.32 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.33% | 0.94% |
| ROE (TTM) | 3.19% | 9.38% |
| Net Profit Margin (TTM) | 7.34% | 16.48% |
| ROIC 5YR AVG | N/A | 17.23% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -1.58% | 105.87% | N/A |
| Revenue | 8.33% | 16.19% | N/A |
| Net Income | -4.22% | 101.73% | N/A |
| Cash Flow | 28.63% | 210.18% | N/A |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 170.65 | 12.29 |
| Quick Ratio (TTM) | 170.65 | 12.50 |
| D/E Ratio (TTM) | 0.95 | 1.03 |
| Interest Coverage (TTM) | 1.06 | 0.73 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 1.41 | 0.43 |
| LTL to 5YR AVG FCF | N/A | 5.75 |
| Shares Outstanding Growth 5YR AVG | N/A | 60.49% |